Aside from Countries outside the arrangement..
Post# of 148172
licensing agreement with Pfizer were experiencing delays in accessing
product...apparently ingredients were in short supply in mid 2022.
June 29th 2023 Pfizer struck a deal with Chinas' CSPC to launch a local brand
Antiviral Paxlovid.
My sense is that Pfizer didn't want the worst kind of publicity amidst a Global
pandemic. They had to cough up the beans.